|
|
Volumn 3, Issue K, 2001, Pages
|
|
Focus on issues in measuring and interpreting changes in the QTc interval duration
|
|
Author keywords
Clinical trial design; Drug development; Drug safety; ECG; QTc interval
|
|
Indexed keywords
CARDIOTOXICITY;
CARDIOVASCULAR RISK;
CONFERENCE PAPER;
DISEASE ASSOCIATION;
DRUG APPROVAL;
DRUG INFORMATION;
DRUG SAFETY;
ECONOMIC ASPECT;
ELECTROCARDIOGRAM;
HUMAN;
INFORMATION SYSTEM;
LONG QT SYNDROME;
PRIORITY JOURNAL;
QT INTERVAL;
QUALITY CONTROL;
REGULATORY MECHANISM;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
SUDDEN DEATH;
TECHNOLOGY;
VALIDATION PROCESS;
|
|
EID: 0034801510
PISSN: 1520765X
EISSN: None
Source Type: Journal
DOI: 10.1016/S1520-765X(01)90014-8 Document Type: Conference Paper |
|
Times cited : (28)
|
|
References (13)
|
